Extensively drug-resistant tuberculosis: a new face to an old pathogen.
about
Tuberculosis vaccines and prevention of infectionStructural and Biochemical Characterization of Mycobacterium tuberculosis CYP142: EVIDENCE FOR MULTIPLE CHOLESTEROL 27-HYDROXYLASE ACTIVITIES IN A HUMAN PATHOGENPiperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside MacrophagesStructure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversityToxicology and drug delivery by cucurbit[n]uril type molecular containersStructural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance.In silico prediction of protein-protein interactions in human macrophages.Antitubercular drug resistance in four healthcare facilities in North IndiaFormulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis.Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisAccurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis StrainsInduction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice.The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.Targeting the "cytokine storm" for therapeutic benefit.Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor design.Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells.A protecting group-free synthesis of deazathiamine: a step toward inhibitor design.Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.Rapid direct testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin on nutrient and blood agar in resource-starved settings.New antibacterials?Rationalization and prediction of drug resistant mutations in targets for clinical anti-tubercular drugs.Exploration of Piperidinols as Potential Antitubercular Agents
P2860
Q26782022-C17CDD98-8F40-497F-866D-1D7B4450DBE9Q27664866-B032E66A-93B6-4CD2-A84E-0BD56464EC3BQ27675714-79361E4B-03A4-453D-A5BC-7A1F6409C4C4Q27685295-EA5BF9C6-100F-4BFC-A01F-E6215CF06001Q28473864-BAD04EA4-1F40-461E-9B8D-3F4CED864B4CQ28818082-5F5F610E-57E5-4947-AE7A-580C4E5D7B11Q33673527-3F07B002-BAB9-4929-8125-D7574AC6766DQ33906285-3724CDAA-D57D-47CE-8A79-AE8171239EF6Q34237349-C869627B-84A6-4783-B39B-A00E52456C1CQ35122485-F600B34F-85E6-4F88-A442-89DF0F0A6A1BQ35676541-8F2AB473-34F2-4751-9D56-DD2351935367Q35839810-3AE6B4E3-3609-4433-8BF1-BE7F7369A20CQ35867371-6EFC1C84-AF38-424D-A896-65D0EA467B75Q36745641-8228A6D0-793D-4BFA-9A32-9116CB58E80BQ37067294-E91056BF-FCA6-40BC-B577-FFB250932ED7Q37855840-28F05200-5780-4F86-9022-610F03547661Q38071254-7571F550-E643-4D3C-A0F4-81EC96BE3FF2Q39648923-1CE66E35-9717-4DAF-82CD-89B3BCF9C32CQ40044806-D3A14C5B-EEEC-453C-AFE3-0339B0BDE92FQ41774630-6D27C3B3-833C-4C3F-979C-115D4D656B3EQ41826690-D64B6D7D-7D5D-4FFA-B9FF-3818658609B1Q42152385-A41B620F-D1E7-41CF-8571-DFB27718A9BDQ42656459-F2013613-C045-45B5-B626-5D7AEDB6789FQ43648589-C2339145-C846-43F7-A274-B329F317CB50Q57976064-0A879F5F-01AA-495D-B073-ED507E9B2149
P2860
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@ast
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@en
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@nl
type
label
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@ast
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@en
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@nl
prefLabel
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@ast
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@en
Extensively drug-resistant tuberculosis: a new face to an old pathogen.
@nl
P2860
P1476
Extensively drug-resistant tuberculosis: a new face to an old pathogen
@en
P2093
Gerald Friedland
P2860
P304
P356
10.1146/ANNUREV.MED.60.053107.103955
P577
2009-01-01T00:00:00Z